
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Kardigan (NASDAQ:KARD) through any online brokerage.
Other companies in Kardigan’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Kardigan has a consensus price target of $38.80.
The stock price for Kardigan (NASDAQ: KARD) is $13.52 last updated October 14, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Kardigan.
Kardigan does not have any upcoming earnings scheduled.
There is no upcoming split for Kardigan.
Kardigan is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved...